{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-004406","form_type":"8-K","ticker":"CRVS","cik":"0001626971","company_name":"Corvus Pharmaceuticals, Inc.","filed_at":"2022-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.542429+00:00","generated_at":"2026-06-25T00:53:29.575878+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Corvus shareholders elect all director nominees, ratify auditor, approve say-on-pay","bullets":["Elected Class III directors: Ian T. Clark (20.9M for), Elisha Gould III (22.6M for), Peter Thompson (17.1M for).","Ratified PricewaterhouseCoopers as fiscal 2022 auditor with 35.3M votes for.","Advisory vote on executive compensation approved (22.6M for, 0.4M against).","Shareholders selected 1-year frequency for future say-on-pay votes (22.5M for 1 year)."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-004406","json":"https://secwatch.observer/filing/0001171843-22-004406.json","markdown":"https://secwatch.observer/filing/0001171843-22-004406.md","text":"https://secwatch.observer/filing/0001171843-22-004406.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626971/000117184322004406/0001171843-22-004406-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626971/000117184322004406/f8k_061722.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:53:29.575878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}